Patented Products Sample Clauses

Patented Products. In any country where the manufacture, use or sale of a Product is covered by a Program Patent or Tularik Patent, royalties shall be payable in such country until the later of (i) seven (7) years from the first commercial sale of such Product in such country and (ii) the expiration of the last to expire of such Program Patent or Tularik Patent.
Sample 1Sample 2See All (5)
AutoNDA by SimpleDocs
Patented Products. Amgen will pay to Progenitor a Royalty on cumulative annual worldwide Net Sales by Amgen, its Affiliates and sublicensees of products, the making, using, selling or importing of which would, but for the licenses to the Licensed Patents granted to Amgen by Progenitor herein, infringe one or more valid, issued claims included within the Licensed Receptor Patents in the country of sale ("Patented Products") as set forth below. - Net Sales of less than or equal to [***][***] of Net Sales - Net Sales greater than [***][***] of Net Sales
Sample 1Sample 2
Patented Products. If a Licensed Product is sold in a country where such Licensed Product is covered by an Enforceable Claim of the Patent Rights, then one hundred percent (100%) of the Net Sales of such Product in such country shall be used to determine the Royalty under subsection (c).
Sample 1Sample 2
Patented Products. SANKYO shall pay a royalty at the rate of ** of the NET SALES of each Product (2/3 of which shall be for the account of OSI and 1/3 of which shall be for the account of MRC CC), the manufacture, use, or sale of ----------------------- ** This portion redacted pursuant to a request for confidential treatment. -33- 35 which is covered by a Valid Claim of the Patent Rights. In the event that OSI's contribution is limited to preparation of assay systems for screening, the royalty rate payable from SANKYO shall be ** of the NET SALES of each Product (2/3 of which shall be for the account of OSI and 1/3 of which shall be for the account of MRC CC). With respect to each Product, SANKYO shall continue to pay such royalty on the sales of such Product in each country until the expiration of the last Valid Claim under the Patent Rights applicable to such Product expires in such country.
Sample 1
Patented Products. For each Product the manufacture, use or sale of which for applications within the Field is covered by a Program Patent, Merck Patent or Tularik Patent, royalties shall be payable in a country until the later of (i) [ * ] from the first commercial sale of the Product in such country, or [ * ].
Sample 1

Related to Patented Products

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Product The term “

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Combination Products If a LICENSED PRODUCT is sold to any third party in combination with other products, devices, components or materials that are capable of being sold separately and are not subject to royalties hereunder (“OTHER PRODUCTS,” with the combination of products being referred to as “COMBINATION PRODUCTS” and the Other Product and Licensed Product in such Combination Product being referred to as the “COMPONENTS”), the NET SALES of such LICENSED PRODUCT included in such COMBINATION PRODUCT shall be calculated by multiplying the NET SALES of the COMBINATION PRODUCT by the fraction A/(A+B), where A is the average NET SALES price of such LICENSED PRODUCT in the relevant country, as sold separately, and B is the total average NET SALES price of all OTHER PRODUCTS in the COMBINATION PRODUCT in the relevant country, as sold separately. If, in any country, any COMPONENT is not sold separately, NET SALES for royalty determination shall be determined by the formula [C / (C+D)], where C is the aggregate average fully absorbed cost of the Licensed Product components during the prior Royalty Period and D is the aggregate average fully absorbed cost of the other essential functional components during the prior Royalty Period, with such costs being determined in accordance with generally accepted accounting principles. To the extent that any SUBLICENSE INCOME relates to a COMBINATION PRODUCT or is otherwise calculated based on the value of one or more licenses or intellectual property rights held by the COMPANY, an AFFILIATE or SUBLICENSEE, COMPANY shall determine in good faith and report to THE PARTIES the share of such payments reasonably attributable to COMPANY’s or such AFFILIATE’s sublicense of the rights granted hereunder, based upon their relative importance and proprietary protection, which portion shall be the SUBLICENSE INCOME. THE PARTIES shall have the right to dispute such sharing determination in accordance with the dispute provisions of the AGREEMENT.

  • Products 1.1. The information (including but not limited to the quantity, rated hashrate, unit price (“Unit Price”), total price for one item (“Total Price (One Item)”), total price for all the items (“Total Purchase Price”) of Products to be purchased by Party B from Party A is as follows (“Products”):

  • Product Marking LICENSEE agrees to xxxx the LICENSED PRODUCTs sold in the United States with all applicable United States patent numbers. All LICENSED PRODUCTs shipped to or sold in other countries shall be marked in such a manner as to conform with the patent laws and practices of the country of manufacture or sale.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!